Back to search

Article

Germline HLA-DQ genotype influences response to CAR T-cell therapy in patients with large B-cell lymphoma

2024-01-12

Abstract excerpt

CD19-directed chimeric antigen receptor (CAR) T cells have greatly improved the prognosis of relapsed/refractory large B-cell lymphoma (rrLBCL), yet treatment failure occurs in more than half of patients, usually in the first 3 months after treatment. While they primarily act through CAR-dependent, HLA-independent recognition of tumor targets, CAR-T cells may also indirectly contribute to long-term tumor immunosur...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0250130a-39e7-5d23-b50a-9cc9e83fc510
DOI
10.1101/2024.01.11.24301087
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Germline HLA-DQ genotype influences response to CAR T-cell therapy in patients with large B-cell lymphomaDOI 10.1101/2024.01.11.24301087
Select a neighboring publication to make it the new centre.